Stay updated on Amivantamab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:29:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide notice about NIH websites transitioning from “Artificial Intelligence” to “Super Intelligence” appears above the error page.
    Difference
    1%
    Check dated 2026-10-24T13:58:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:46:32.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T13:56:49.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study content with an access-denied view. As a result, standard study details and related documents are not accessible.
    Difference
    18%
    Check dated 2026-09-19T14:28:17.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page's revision history now shows a new build version v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T14:23:33.000Z thumbnail image

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.